Federal regulators have warned Medtronic that it has failed to complete legally required steps to deal with reported flaws in one of its best-selling external defibrillators.
The device, known as the Lifepak 12, is used by emergency response teams and in hospital emergency rooms to deliver jolts of electricity that can sometimes restore normal heartbeats to patients whose hearts have suddenly stopped.
